Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors.
Kim J, Jang TW, Choi CM, Kim MH, Lee SY, Park CK, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH. Kim J, et al. Among authors: kim sj, kim mh. Transl Lung Cancer Res. 2023 Jun 30;12(6):1197-1209. doi: 10.21037/tlcr-22-832. Epub 2023 Jun 12. Transl Lung Cancer Res. 2023. PMID: 37425421 Free PMC article.
Development of a prognosis-prediction model incorporating genetic polymorphism with pathologic stage in stage I non-small cell lung cancer: A multicenter study.
Lee WK, Lee SY, Choi JE, Seok Y, Lee EB, Lee HC, Kang HG, Yoo SS, Lee MH, Cho S, Jheon S, Kim YC, Oh IJ, Na KJ, Jung CY, Park CK, Kim MH, Lee MK, Park JY. Lee WK, et al. Among authors: kim yc, kim mh. Thorac Cancer. 2017 May;8(3):251-259. doi: 10.1111/1759-7714.12434. Epub 2017 Mar 31. Thorac Cancer. 2017. PMID: 28371058 Free PMC article.
Effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer.
Yoo SS, Kang HG, Choi JE, Do SK, Lee WK, Choi SH, Lee SY, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Kim MS, Lee JM, Cho HJ, Oh IJ, Kim YC, Cho S, Jheon S, Jung CY, Kim MH, Lee MK, Park JY. Yoo SS, et al. Among authors: kim ch, kim ms, kim yc, kim mh. Cancer Genet. 2017 Apr;212-213:8-12. doi: 10.1016/j.cancergen.2017.03.003. Epub 2017 Mar 20. Cancer Genet. 2017. PMID: 28449811
Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea.
Kim T, Jang TW, Choi CM, Kim MH, Lee SY, Park CK, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH. Kim T, et al. Among authors: kim sj, kim mh. Cancer Med. 2021 Sep;10(17):5809-5822. doi: 10.1002/cam4.4127. Epub 2021 Jul 13. Cancer Med. 2021. PMID: 34258882 Free PMC article.
Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial.
Park CK, Oh HJ, Yoo SS, Lee SY, Lee SH, Kim EY, Lee SY, Choi J, Lee MK, Kim MH, Jang TW, Chung C, Oh IJ, Kim YC. Park CK, et al. Among authors: kim ey, kim yc, kim mh. Transl Lung Cancer Res. 2022 Aug;11(8):1606-1618. doi: 10.21037/tlcr-22-183. Transl Lung Cancer Res. 2022. PMID: 36090637 Free PMC article.
4,475 results